BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Treatment
402 results:

  • 1. Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung cancer: A Meta-Analysis.
    Chi C; Wang C; Dong L; Li X; Xu L
    J Coll Physicians Surg Pak; 2024 Apr; 34(4):461-467. PubMed ID: 38576291
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. OGDH and Bcl-xL loss causes synthetic lethality in glioblastoma.
    Nguyen TT; Torrini C; Shang E; Shu C; Mun JY; Gao Q; Humala N; Akman HO; Zhang G; Westhoff MA; Karpel-Massler G; Bruce JN; Canoll P; Siegelin MD
    JCI Insight; 2024 Mar; 9(8):. PubMed ID: 38483541
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Pineal anlage tumor: clinical and diagnostic features, and rationales for treatment.
    Obrecht-Sturm D; Pfaff E; Mynarek M; Bison B; Rodehüser M; Becker M; Kietz S; Pfister SM; Jones DT; Sturm D; von Deimling A; Sahm F; Kortmann RD; Schwarz R; Pietsch T; Fleischhack G; Rutkowski S
    J Neurooncol; 2024 Jan; 166(2):359-368. PubMed ID: 38253790
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A longitudinal evaluation of smell and taste function in children with cancer during and after treatment with chemotherapy.
    van den Brink M; Havermans RC; Fiocco M; Tissing WJE
    Appetite; 2024 Feb; 193():107174. PubMed ID: 38128763
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Sequential Rocket-Mode Bioactivating Ticagrelor Prodrug Nanoplatform Combining Light-Switchable Diphtherin Transgene System for Breast cancer Metastasis Inhibition.
    Zou J; Sun R; He M; Chen Y; Cheng Y; Xia C; Ma Y; Zheng S; Fu X; Yuan Z; Lan M; Lou K; Chen X; Gao F
    ACS Appl Mater Interfaces; 2023 Nov; 15(46):53198-53216. PubMed ID: 37942626
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia.
    Shin JE; Kim SH; Kong M; Kim HR; Yoon S; Kee KM; Kim JA; Kim DH; Park SY; Park JH; Kim H; No KT; Lee HW; Gee HY; Hong S; Guan KL; Roe JS; Lee H; Kim DW; Park HW
    Mol Cancer; 2023 Nov; 22(1):177. PubMed ID: 37932786
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Access to Methotrexate Monitoring in Latin America: A Multicountry Survey of Supportive Care Capacity.
    Villanueva G; Lowe J; Tentoni N; Taluja A; Villarroel M; Narváez CE; León SA; Valencia Libreros DL; Gonzalez Suárez N; Mikkelsen TS; Howard SC
    Pediatr Hematol Oncol; 2024; 41(2):135-149. PubMed ID: 37865916
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The feasibility of implementing Toronto childhood cancer stage guidelines and estimating the impact on outcome for childhood cancers in seven pediatric oncology units in sub-Saharan Africa. A study from the Franco-African Pediatric Oncology Group.
    Mallon B; Kaboré R; Couitchere L; Akonde FB; Narison MLR; Budiongo A; Dackono TA; Pondy A; Diedhiou F; Patte C; Steliarova-Foucher E; Clavel J
    Pediatr Blood Cancer; 2023 Dec; 70(12):e30664. PubMed ID: 37732944
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia.
    Li T; Kandula T; Cohn RJ; Kiernan MC; Park SB; Farrar MA
    Clin Neurophysiol; 2023 Oct; 154():157-168. PubMed ID: 37633123
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Transcription factor abnormalities in B-ALL leukemogenesis and treatment.
    Yin H; Wang J; Tan Y; Jiang M; Zhang H; Meng G
    Trends Cancer; 2023 Oct; 9(10):855-870. PubMed ID: 37407363
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Cost‑Effectiveness of Lorlatinib in First-Line treatment of Adult Patients with Anaplastic Lymphoma Kinase (ALK)‑Positive Non‑Small‑Cell Lung cancer in Sweden.
    Naik J; Beavers N; Nilsson FOL; Iadeluca L; Lowry C
    Appl Health Econ Health Policy; 2023 Jul; 21(4):661-672. PubMed ID: 37173513
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The EMA Assessment of Asciminib for the treatment of Adult Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Who Were Previously Treated With at Least Two Tyrosine Kinase Inhibitors.
    Tesileanu CMS; Michaleas S; Gonzalo Ruiz R; Mariz S; Fabriek BO; van Hennik PB; Dedorath J; Dekic B; Unkrig C; Brandt A; Koenig J; Enzmann H; Delgado J; Pignatti F
    Oncologist; 2023 Jul; 28(7):628-632. PubMed ID: 37141403
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Childhood cancer survival in the highly vulnerable population of South Texas: A cohort study.
    Wu S; Liu Y; Williams M; Aguilar C; Ramirez AG; Mesa R; Tomlinson GE
    PLoS One; 2023; 18(4):e0278354. PubMed ID: 37022991
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cumulative burden of 144 conditions, critical care hospitalisation and premature mortality across 26 adult cancers.
    Chang WH; Neal RD; Forster MD; Lai AG
    Nat Commun; 2023 Mar; 14(1):1484. PubMed ID: 36932095
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Single-Cell Transcriptomics Reveals Immune Reconstitution in Patients with R/R T-ALL/LBL Treated with Donor-Derived CD7 CAR-T Therapy.
    Chen W; Shi H; Liu Z; Yang F; Liu J; Zhang L; Wu Y; Xia Y; Ou Y; Li R; Zhang T; Zhang J; Ke X; Hu K; Yu J
    Clin Cancer Res; 2023 Apr; 29(8):1484-1495. PubMed ID: 36735547
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS data.
    Cheema P; Cho BC; Freitas H; Provencio M; Chen YM; Kim SW; Wu YL; Passaro A; Martin C; Tiseo M; Chang GC; Park K; Solomon B; Burghuber O; Laskin J; Wang Z; Lee SY; Hu Y; Vansteenkiste J; Zhang HL; Hanrahan E; Geldart T; Taylor R; Servidio L; Li J; Marinis F
    Future Oncol; 2023 Jan; 19(1):61-75. PubMed ID: 36656302
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. 1000 Days: The "WeCare Generation" Program-The Ultimate Model for Improving Human Mental Health and Economics: The Study Protocol.
    Uccellini O; Benlodi A; Caroppo E; Cena L; Esposito G; Fernandez I; Ghazanfar M; Imbasciati A; Longo F; Mazza M; Marano G; Nacinovich R; Pignatto A; Rolnick A; Trivelli M; Spada E; Vanzini C
    Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554625
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. CXCR4 antagonists disrupt leukaemia-meningeal cell adhesion and attenuate chemoresistance.
    Jonart LM; Ostergaard J; Brooks A; Fitzpatrick G; Chen L; Gordon PM
    Br J Haematol; 2023 May; 201(3):459-469. PubMed ID: 36535585
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Central Nervous System Prophylaxis and treatment in Acute Leukemias.
    Wu SY; Short NJ; Nasr L; Dabaja BS; Fang PQ
    Curr Treat Options Oncol; 2022 Dec; 23(12):1829-1844. PubMed ID: 36510037
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Real-world outcomes of anti-EGFR therapy in advanced non-small cell lung cancer EGFR mutated in Peru.
    Galvez-Nino M; Ruiz R; Roque K; Coanqui O; Valdivieso N; Olivera M; Ganti AK; Mas L
    Thorac Cancer; 2023 Jan; 14(1):61-67. PubMed ID: 36369763
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 21.